Filing Flows › Steris (STE) › Q1 FY27 › vs Q1 FY26
Steris (STE) Q1 FY27 vs Q1 FY26 (year over year)
Steris's revenue rose $102M (+7%) from $1.4B in Q1 FY26 to $1.5B in Q1 FY27. The biggest changes: Healthcare +$73.6M (+8%); Applied Sterilization Technologies +$16.4M (+6%); Life Sciences: +$11.5M (+9%). Gross margin 45.8% against 45.1% (+0.7 pts).
Steris, Q1 FY27: revenue $1.5B (+7% year over year), operating margin 19.1%, net earnings $201M, operating cash flow $367M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 45.8% | 45.1% | +0.7 pts |
| Operating margin | 19.1% | 17.7% | +1.5 pts |
| Net margin | 13.5% | 12.8% | +0.7 pts |
| Free cash flow margin | 18.7% | 23.5% | -4.7 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Healthcare | $1.0B | $975M | $73.6M | +8% |
| Applied Sterilization Technologies | $298M | $281M | $16.4M | +6% |
| Life Sciences: | $147M | $135M | $11.5M | +9% |
| Revenue | $1.5B | $1.4B | $102M | +7% |
| Gross profit | $684M | $628M | $56.2M | +9% |
| Cost of revenue | $808M | $763M | $45.4M | +6% |
| Operating profit | $286M | $246M | $39.8M | +16% |
| Operating expenses | $398M | $382M | $16.4M | +4% |
| Pre-tax earnings | $274M | $232M | $41.6M | +18% |
| Other expense, net | $12.3M | $14.1M | −$1.8M | -13% |
| Research & development | $28.6M | $26.4M | $2.2M | +8% |
| SG&A | $370M | $354M | $15.9M | +4% |
| Net earnings | $201M | $178M | $23.0M | +13% |
| Income tax | $72.5M | $53.9M | $18.6M | +35% |
| Depreciation & amortization | $124M | $119M | $4.4M | +4% |
| Share-based compensation | $12.8M | $11.9M | $900K | +8% |
| Working capital & other | $29.5M | $111M | −$81.2M | -73% |
| Operating cash flow | $367M | $420M | −$52.9M | -13% |
| Free Cash Flow (company-reported) | $280M | $326M | −$46.9M | -14% |
| Purchases of property, plant, equipment, and intangibles, net | $87.5M | $93.5M | −$6.0M | -6% |
Questions
How much did Steris's revenue grow year over year in Q1 FY27?
Steris's revenue rose $102M (+7%) from $1.4B in Q1 FY26 to $1.5B in Q1 FY27.
What drove Steris's revenue change in Q1 FY27?
Healthcare +$73.6M (+8%); Applied Sterilization Technologies +$16.4M (+6%); Life Sciences: +$11.5M (+9%).